The alvimopan cohort experienced quicker GI-@ recovery ( @ vs @ d ; hazard ratio : @ ; p < @ ) , shorter mean LOS ( @ vs @ d ; p = @ ) , and fewer episodes of POI-related morbidity ( @ % vs @ % ; p < @ ) .